204 related articles for article (PubMed ID: 2862651)
1. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
Shearman GT; Schulz R; Schiller PW; Herz A
Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
[TBL] [Abstract][Full Text] [Related]
2. D-Ala2,D-Leu5-enkephalin generalizes to a discriminative stimulus produced by fentanyl but not ethylketocyclazocine.
Shearman GT; Herz A
Pharmacol Biochem Behav; 1982 Feb; 16(2):249-52. PubMed ID: 6280202
[TBL] [Abstract][Full Text] [Related]
3. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
Laurent S; Schmitt H
Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.
Shearman GT; Herz A
Psychopharmacology (Berl); 1982; 78(1):63-6. PubMed ID: 6292982
[TBL] [Abstract][Full Text] [Related]
5. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
[TBL] [Abstract][Full Text] [Related]
6. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Ca++-ATPase of rat erythrocyte membranes by k-opioid agonists.
Yamasaki Y; Way EL
Neuropeptides; 1985 Feb; 5(4-6):359-62. PubMed ID: 2860593
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
Ramme D; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):57-61. PubMed ID: 2869418
[TBL] [Abstract][Full Text] [Related]
9. Centrally-administered opioid selective agonists inhibit drinking in the rat.
Spencer RL; Deupree D; Hsiao S; Mosberg HI; Hruby V; Burks TF; Porreca F
Pharmacol Biochem Behav; 1986 Jul; 25(1):77-82. PubMed ID: 2875475
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
Tiseo PJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 1988 Aug; 246(2):449-53. PubMed ID: 2900324
[TBL] [Abstract][Full Text] [Related]
11. Dynorphin-(1-13) restores the potency of morphine on the tolerant guinea pig ileum.
Rezvani A; Way EL
Eur J Pharmacol; 1984 Jul; 102(3-4):475-9. PubMed ID: 6149134
[TBL] [Abstract][Full Text] [Related]
12. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
Chavkin C; James IF; Goldstein A
Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.
Moises HC; Walker JM
Eur J Pharmacol; 1985 Jan; 108(1):85-98. PubMed ID: 2858395
[TBL] [Abstract][Full Text] [Related]
14. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration.
Werz MA; Macdonald RL
J Pharmacol Exp Ther; 1985 Jul; 234(1):49-56. PubMed ID: 2409273
[TBL] [Abstract][Full Text] [Related]
15. Opioid receptor types on adrenergic nerve terminals of rabbit ear artery.
Fukuda H; Hosoki E; Ishida Y; Moritoki H
Br J Pharmacol; 1985 Nov; 86(3):539-45. PubMed ID: 2998521
[TBL] [Abstract][Full Text] [Related]
16. Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin.
Liebmann C; Schrader U; Brantl V
Eur J Pharmacol; 1989 Aug; 166(3):523-6. PubMed ID: 2553436
[TBL] [Abstract][Full Text] [Related]
17. The choice of opiate receptor subtype by neo-endorphins.
Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
[TBL] [Abstract][Full Text] [Related]
18. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit.
Jackisch R; Geppert M; Brenner AS; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):156-62. PubMed ID: 2871497
[TBL] [Abstract][Full Text] [Related]
20. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
Kirby GC; McQueen DS
Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
